AINewsnow

Autonomous Drug Discovery RevOps: Eliminating Scientific-to-Commercial Friction with Agentic AI

This story is from 2026-10-02. It is preserved in the archive; the latest stories are on the live feed.

Disconnected LIMS, ELNs, and CRM platforms delay biopharma revenue realization, but Agentic AI autonomously synchronizes laboratory capacity, scientific intent signals, and milestone-based forecasting. The Core Operational Friction The Industry Bottleneck Modern Drug Discovery Revenue Operations (R…

Read the full story at DEV Community — AI ↗

Timeline · 1 report

  1. 2026-10-02 00:30 · DEV Community — AI
    Autonomous Drug Discovery RevOps: Eliminating Scientific-to-Commercial Friction with Agentic AI

More stories

  1. Bring near-Astra intelligence to everyday work with GPT-6.1 Sol on Amazon Bedrock — AWS Machine Learning Blog
  2. Gemini 4 Argon: our next era of frontier intelligence — Google Gemini Blog
  3. Introducing Olmo-core 3: Open, scalable training infrastructure for large MoEs — Allen Institute for AI (Ai2)
  4. Google Releases New Gemini Model With Guardrails Amid A.I. Safety Debate — New York Times Technology
  5. OpenAI halts model release over safety concerns: "Didn't quite meet the bar" — CBS News Technology
  6. OpenAI DevDay 2026 Keynote (FULL) — OpenAI YouTube
  7. Introducing GPT-6.1 Sol — OpenAI News
  8. OpenAI’s Dots Are Always-On AI Agents—and Its Answer to Meta’s Muse — Wired AI

Get the daily brief of stories like this at 6:30 every morning →